Marshall Wace North America’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$601K Sell
32,959
-368,008
-92% -$4.07M ﹤0.01% 1072
2021
Q2
$4.48M Buy
400,967
+357,312
+818% +$5.63M 0.02% 580
2021
Q1
$1.07M Buy
+43,655
New +$488K ﹤0.01% 1014

Other funds holding AMTX

Marshall Wace North America's AMTX Position: Q3 2021 in Review

Marshall Wace North America reduced its Aemetis (AMTX) stake by 92% in Q3 2021, selling an estimated $4.07M and leaving 32,959 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Marshall Wace North America first reported a position in AMTX in Q1 2021 and has held it in 3 quarters since. The position peaked at $4.48M in Q2 2021. 84 funds tracked by Wall St. Rank hold AMTX as of Q3 2021.

  • Marshall Wace North America held 32,959 shares of Aemetis worth $601K as of Q3 2021.
  • Marshall Wace North America sold 368,008 Aemetis shares in Q3 2021, an estimated $4.07M.
  • Aemetis made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1072 holding.
  • Marshall Wace North America first reported a position in Aemetis in Q1 2021 and has held it in 3 quarters since.
  • Marshall Wace North America's Aemetis position peaked at $4.48M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Aemetis as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.